| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |